↓ Skip to main content

Cochrane Database of Systematic Reviews

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, November 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

twitter
9 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
324 Mendeley
Title
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, November 2020
DOI 10.1002/14651858.cd013516.pub2
Pubmed ID
Authors

Emil Ørskov Ipsen, Kasper S Madsen, Yuan Chi, Ulrik Pedersen-Bjergaard, Bernd Richter, Maria-Inti Metzendorf, Bianca Hemmingsen

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 324 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 324 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 50 15%
Student > Bachelor 39 12%
Researcher 26 8%
Unspecified 14 4%
Professor 14 4%
Other 59 18%
Unknown 122 38%
Readers by discipline Count As %
Medicine and Dentistry 88 27%
Nursing and Health Professions 37 11%
Unspecified 14 4%
Pharmacology, Toxicology and Pharmaceutical Science 10 3%
Psychology 7 2%
Other 34 10%
Unknown 134 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#4,158,147
of 25,462,162 outputs
Outputs from Cochrane database of systematic reviews
#6,496
of 12,090 outputs
Outputs of similar age
#103,405
of 517,430 outputs
Outputs of similar age from Cochrane database of systematic reviews
#106
of 136 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 517,430 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.